Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre de la Taille

Showing results (351-360 of 360) with videos related to

Pageof 36
Sort By:
You have reached the last page of results.This site can display upto 360 results.
BJU International|September 8, 2007
Unclassified renal cell carcinoma: an analysis of 85 casesPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
World Journal of Urology|September 25, 2025
Impact of intra-abdominal pressure with AirSeal<sup>®</sup> system on patient-reported outcomes and experience measurements after robot-assisted radical prostatectomyBogdan Adrian Buhas, Olivier Skowron, Martin Sié, et al.
BJU International|January 17, 2023
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15)Astrid Boulenger de Hauteclocque, Loïc Ferrer, Damien Ambrosetti, et al.
The Journal of Urology|October 19, 2010
The learning curve for laparoscopic radical prostatectomy: an international multicenter studyFernando P Secin, Caroline Savage, Claude Abbou, et al.
The Journal of Urology|May 11, 2019
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic ApproachesPaolo Gontero, Giancarlo Marra, Paolo Alessio, et al.
The Lancet. Oncology|April 7, 2022
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trialYann-Alexandre Vano, Réza Elaidi, Mostefa Bennamoun, et al.
Urologic Oncology|January 13, 2021
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective studyGiancarlo Marra, Robert Jeffrey Karnes, Giorgio Calleris, et al.
European Urology|April 11, 2009
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgeryKarim Bensalah, Allan J Pantuck, Nathalie Rioux-Leclercq, et al.
World Journal of Urology|November 7, 2019
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 casesPaolo Gontero, Francesca Pisano, Joan Palou, et al.
Pageof 36

Showing results (351-360 of 360) with videos related to

Sort By:
Pageof 36
You have reached the last page of results.This site can display upto 360 results.
BJU International|September 8, 2007
Unclassified renal cell carcinoma: an analysis of 85 casesPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
World Journal of Urology|September 25, 2025
Impact of intra-abdominal pressure with AirSeal<sup>®</sup> system on patient-reported outcomes and experience measurements after robot-assisted radical prostatectomyBogdan Adrian Buhas, Olivier Skowron, Martin Sié, et al.
BJU International|January 17, 2023
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15)Astrid Boulenger de Hauteclocque, Loïc Ferrer, Damien Ambrosetti, et al.
The Journal of Urology|October 19, 2010
The learning curve for laparoscopic radical prostatectomy: an international multicenter studyFernando P Secin, Caroline Savage, Claude Abbou, et al.
The Journal of Urology|May 11, 2019
Salvage Radical Prostatectomy for Recurrent Prostate Cancer: Morbidity and Functional Outcomes from a Large Multicenter Series of Open versus Robotic ApproachesPaolo Gontero, Giancarlo Marra, Paolo Alessio, et al.
The Lancet. Oncology|April 7, 2022
Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trialYann-Alexandre Vano, Réza Elaidi, Mostefa Bennamoun, et al.
Urologic Oncology|January 13, 2021
Oncological outcomes of salvage radical prostatectomy for recurrent prostate cancer in the contemporary era: A multicenter retrospective studyGiancarlo Marra, Robert Jeffrey Karnes, Giorgio Calleris, et al.
European Urology|April 11, 2009
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgeryKarim Bensalah, Allan J Pantuck, Nathalie Rioux-Leclercq, et al.
World Journal of Urology|November 7, 2019
Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 casesPaolo Gontero, Francesca Pisano, Joan Palou, et al.
Pageof 36